Aortic stenosis trials in China
25 of 42 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleVericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression
- Where
- Chengdu
- Age
- 35 years to 80 years
- People
- 238
- Run by
- West China Hospital
See details and how to joinNCT07715279 - Phase 3Taking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Beijing
- Age
- 2 years to 11 years
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - Phase 3Taking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Beijing, Shanghai
- Age
- 6 years to 11 years
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019 - Phase 4Not yet taking people in ChinaEcho-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis(ECHO-TAVR)
- Where
- Beijing
- Age
- 65 years and over
- People
- 212
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT07317804 - No phaseTaking peopleCLEAR-AS: CT-FFR-Guided Revascularization in Patients With Severe Aortic Stenosis
- Where
- Kunming
- Age
- 18 years and over
- People
- 300
- Run by
- Yan'an Affiliated Hospital of Kunming Medical University
See details and how to joinNCT07469371 - Phase 3Not yet taking people in ChinaPCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis
- Where
- Beijing
- Age
- 18 years to 85 years
- People
- 160
- Run by
- Beijing Anzhen Hospital
See details and how to joinNCT07256197 - No phaseTaking peopleTransaxillary TAVR With Solely Echocardiography Guidance
- Where
- Beijing
- People
- 20
- Run by
- Chinese Academy of Medical Sciences, Fuwai Hospital
See details and how to joinNCT07035847 - No phaseTaking peopleSafety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis
- Where
- Beijing
- Age
- 60 years to 100 years
- People
- 800
- Run by
- Beijing Balance Medical Technology Co., Ltd
See details and how to joinNCT07414342 - No phaseTaking peopleA Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis
- Where
- Shanghai
- Age
- 18 years and over
- People
- 25
- Run by
- RenJi Hospital
See details and how to joinNCT07335900 - No phaseEnrolling by invitationTAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 452
- Run by
- Shanghai MicroPort CardioFlow Medtech Co., Ltd.
See details and how to joinNCT06597188 - No phaseTaking peopleProspective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions
- Where
- Shanghai
- Age
- 18 years and over
- People
- 232
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07145463 - No phaseTaking peopleEarly Feasibility Study of Surgical Implantation of a Polymer Prosthetic Mitral and Aortic Valve
- Where
- Shanghai
- Age
- 50 years and over
- People
- 10
- Run by
- Mitrassist Lifesciences Limited Co., Ltd.
See details and how to joinNCT07097740 - No phaseEnrolling by invitationVideodensitometric Angiographic Assessment of AR in the Cath-lab for Intraprocedural Guidance of TAVI in CHINA
- Where
- Shanghai, Xi'an
- Age
- 18 years and over
- People
- 320
- Run by
- Xijing Hospital
See details and how to joinNCT06891079 - No phaseTaking peopleEfficacy of Self-expandable and Balloon-expandable Valves in Patients With Ascending Aortic Dilation
- Where
- Beijing, Kunming, Shenzhen
- Age
- 65 years and over
- People
- 100
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT06743568 - No phaseEnrolling by invitationEvaluating the Safety and Efficacy of Prosthetic Polymer Heart Valves for the Treatment of Aortic Valve Disease
- Where
- Shanghai
- Age
- 18 years and over
- People
- 10
- Run by
- Suzhou Hearthill Medical Technology Co.,LTD
See details and how to joinNCT06518681 - No phaseNot yet taking people in ChinaStudy of Transcatheter Aortic Valve Replacement With A² Flex and Commissural Alignment Technology in Severe Aortic Stenosis
- Where
- Suzhou
- Age
- 60 years and over
- People
- 10
- Run by
- Peijia Medical Technology (Suzhou) Co., Ltd.
See details and how to joinNCT06721676 - No phaseTaking peopleIntensive Treatment on Periodontitis in Aortic Stenosis
- Where
- Beijing
- Age
- 18 years and over
- People
- 920
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT06587971 - Phase 3Taking peopleEffect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis
- Where
- Beijing
- Age
- 18 years and over
- People
- 160
- Run by
- Beijing Anzhen Hospital
See details and how to joinNCT04968509 - No phaseTaking peoplePrizvalve Pro™ Transcatheter Aortic Valve Replacement Study
- Where
- Shanghai
- Age
- 65 years and over
- People
- 73
- Run by
- Shanghai NewMed Medical Co., Ltd.
See details and how to joinNCT05864456 - No phaseTaking peopleA Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis
- Where
- Beijing
- Age
- 70 years and over
- People
- 120
- Run by
- Pan Xiangbin
See details and how to joinNCT06136429 - No phaseNot yet taking people in ChinaA Clinical Trial of the Transcatheter Aortic Valve Implantation System With a Prospective, Multi-Center, One-Arm Approach to Evaluate the Efficacy and Safety in the Treatment of Patients With Severe Aortic Stenosis
- Where
- Beijing
- Age
- 65 years and over
- People
- 131
- Run by
- Chinese Academy of Medical Sciences, Fuwai Hospital
See details and how to joinNCT05673525 - Phase 4Taking peopleTranscatheter Aortic Valve Replacement Single Center Registry in Chinese Population
- Where
- Hanzhou
- Age
- 18 years and over
- People
- 2,000
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT02803294 - No phaseTaking peopleHANGZHOU Solution in Bicuspid AS Undergoing TAVR
- Where
- Beijing, Bengbu, Changsha, Fuzhou, Guangzhou, Hangzhou, Nanchang, Ningbo, Qingdao, Taiyuan, Tianjing, Wuhan, Xiamen, Yangzhou, Zhengzhou
- Age
- 60 years and over
- People
- 508
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04722796 - No phaseTaking peopleTo Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Stenosis
- Where
- Beijing
- Age
- 70 years and over
- People
- 120
- Run by
- Chengdu Silara Meditech Inc.
See details and how to joinNCT04893603 - No phaseTaking peopleVitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial
- Where
- Beijing, Chengdu, Hangzhou, Shanghai
- Age
- 70 years and over
- People
- 145
- Run by
- Shanghai MicroPort CardioFlow Medtech Co., Ltd.
See details and how to joinNCT04414878